Thoughts on JP Morgan Conference
There is a lot of good commentary and analysis of last week's JP Morgan Healthcare conference, most notably here, here, and here. Here are a few of our thoughts as…
Menu
More Government Involvement in Pharma Industry
The past few months have seen a number of reports describing how national governments are using policy to spur local pharmaceutical industry growth. We have already described examples from Brazil,…
Brazil’s prescription for pharma: More Government involvement
Earlier this week we wrote about the emerging trend of increasing state government involvement in the pharmaceutical industry. Today we learn about what the government in Brazil is doing. Of…
Drug Development and Delivery: What’s in a name?
Our good friends at Drug Delivery Technology have, as of January, changed the name of their publication to Drug Development and Delivery. Why is this significant? We think that drug…
More on Russia…Is the US Next?
Last week we wrote about the Russian government's desire to grow their national pharmaceutical infrastructure. Our reading of the situation is that the government will "suggest" that ex-Russia companies who…
India, India, and more about India
Here is a sample of announcements from today alone regarding the pharmaceutical industry in India: First, UK-based Reckitt Benckiser is acquiring Paras Pharmaceuticals for $726 million. Paras makes a variety…
Russian government spurs pharma growth
Earlier this week, Prime Minister Putin announced that the Russian government will invest nearly $4 billion to modernize the pharmaceutical industry in Russia. Of note: Putin said he wanted 90…
Pfizer bypassing wholesalers in Oz
There is fascinating news today from Pfizer, who have decided to bypass the wholesalers in Australia and market directly to community pharmacies. To quote, "In order to develop stronger partnerships with…
The Indian Connection
The Indian pharmaceutical market is highly fragmented. How can pharma companies make money? PharmaTimes characterizes the market for us in summary form.
Launch evolution across Pharmerging Markets
PharmaPhorum has an excellent analysis on launch evolution across pharmerging markets, such as China, Brazil, Russia, and so forth. A few items of note: 1. The author projects that by…